Table 1.
Characteristics of the studies included in the meta-analysis.
Figure 1.
Meta-analysis of rs2046210 and breast cancer risk (allele contrast).
Figure 2.
Meta-analysis of rs2046210 and breast cancer risk (dominant model).
Figure 3.
Meta-analysis of rs2046210 and breast cancer risk (recessive model).
Table 2.
Meta-analysis of rs2046210 on breast cancer risk.
Figure 4.
Subgroup meta-analysis of rs2046210 and the risk of ER-negative breast cancer (allele contrast).
Figure 5.
Subgroup meta-analysis of rs2046210 and the risk of ER-positive breast cancer (allele contrast).